杭叉集團(603298.SH):擬以不超6億元自有閒置資金進行投資理財
格隆匯4月7日丨杭叉集團(603298.SH)公佈,公司於2022年4月7日召開第六屆董事會第二十八次會議和第六屆監事會第十六次會議,分別審議通過了《關於使用閒置自有資金進行現金管理的議案》,同意為合理利用閒置自有資金,提高資金使用效率,以增加公司收益,在確保資金安全性、流動性的基礎上實現資金的保值增值,以不超過6億元人民幣的自有閒置資金進行投資理財,在前述額度內,資金可循環使用,授權期限自2022年4月7日起12個月內,同時由董事會授權董事長在額度範圍內行使決策權並簽署相關合同文件或協議等資料,公司管理層組織相關部門實施,公司獨立董事發表了明確同意的獨立意見,該議案無需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.